PLOS ONE APC and Open Access: The World's Largest Journal at One of the Lowest Prices

PLOS ONE was the original megajournal, launched in 2006 by the Public Library of Science. It pioneered the concept of peer review based solely on scientific soundness rather than perceived novelty or impact. If the methods are sound and the conclusions are supported by the data, PLOS ONE will publish it.

This editorial philosophy changed academic publishing permanently. Scientific Reports (Springer Nature), PeerJ, Frontiers journals, and others all followed the model PLOS ONE created. The megajournal category now accounts for hundreds of thousands of articles per year across publishers.

PLOS ONE's impact factor sits at 2.9 (2024). That number has declined from its peak of 4.4 in 2012, which reflects both the journal's enormous volume and the field's general shift in how impact factors are distributed. For researchers in fields where journal brand matters less than accessibility and speed, the IF number is secondary to the practical advantages.

The journal is indexed in PubMed, Scopus, Web of Science, and every other major database. Articles receive DOIs, appear in Google Scholar, and are treated identically to articles in any other peer-reviewed journal for tenure, grants, and citations.

PLOS operates a unique institutional partnership called "All-In" that eliminates APCs entirely for affiliated researchers. Under All-In agreements, the university pays PLOS a flat annual fee based on historical publication volume. In return, all corresponding authors at that institution publish in PLOS journals with no individual APC.

The All-In model is expanding. PLOS has been actively negotiating with libraries and consortia to increase institutional coverage. If your university recently signed an agreement, you may have zero-cost PLOS ONE access without knowing it. Check your library's open access partnerships page.

For institutions without All-In agreements, many maintain OA funds that cover APCs at PLOS ONE's level. A $1,695 charge falls well within the limits of most university OA funds, which typically cap at $2,500-$5,000.

PLOS has one of the most generous waiver programs in academic publishing:

Full waivers: Corresponding authors in countries classified as lower-income by the World Bank receive automatic full waivers. This covers researchers across sub-Saharan Africa, parts of South Asia, and other qualifying regions.

Partial fee assistance: Authors who can't afford the full APC but aren't in waiver-eligible countries can request partial fee assistance. PLOS evaluates these on a case-by-case basis. Approval rates are relatively high compared to commercial publishers.

Process: Fee assistance requests are submitted through the PLOS author portal during the payment stage. The finance team handles all requests. Editors and reviewers never see whether you requested a waiver or what you're paying.

No impact on review: PLOS explicitly states that fee assistance requests don't affect editorial decisions. The manuscript review process is completely separated from the payment process.

PLOS doesn't publish exact waiver statistics, but they've stated publicly that they waive or reduce fees for a significant percentage of authors annually. The organization's mission is open access to scientific knowledge, and their waiver program reflects that.

PLOS ONE publishes all articles under a CC BY license. This is non-negotiable. You can't choose CC BY-NC or any other variant.

CC BY is the most permissive Creative Commons license. It allows anyone to read, download, copy, distribute, print, search, link to, and reuse the work for any purpose, including commercial use, as long as they provide proper attribution.

For funder compliance, this is perfect. Every major funder mandate that specifies a license requires CC BY. PLOS ONE meets this automatically without any action from the author.

Some researchers are uncomfortable with the commercial reuse provision. It's worth understanding what this means in practice: pharmaceutical companies or textbook publishers could reuse your figures or data without asking permission. For most researchers, this isn't an issue. The work gets more exposure, and you get cited. But if commercial reuse is a genuine concern for your specific research, PLOS ONE may not be the right fit.

PLOS ONE satisfies every major public access mandate. Full stop.

This universal compliance is one of PLOS ONE's strongest selling points. You'll never have a funder compliance issue. There's no license to select, no embargo to manage, no workaround needed. Submit, get accepted, the compliance happens automatically.

PLOS also handles PMC deposit automatically. Your article appears in PubMed Central without any action on your part.

PLOS ONE is transparent about its fee structure. The $1,695 APC is the only charge. No page fees, no color charges, no supplementary data fees, no submission fee. However:

• Data deposition: PLOS ONE has strict data availability requirements. All data underlying your findings must be publicly available. This usually means depositing in a public repository (Dryad, Figshare, institutional repositories). Most are free for standard datasets, but very large files (genomics, imaging) may incur storage fees.
• Formatting: PLOS ONE accepts manuscripts in most common formats and doesn't require journal-specific formatting at submission. This saves time compared to journals with strict formatting requirements. Reformatting after acceptance is handled by PLOS production.
• Revision timeline: If your paper requires major revision, you typically get 30-60 days. Extensions are available on request. No fee associated with revisions.
• Withdrawal after acceptance: If you withdraw your article after acceptance, PLOS doesn't charge the APC. Some publishers do. This is a genuinely author-friendly policy.
• Preprints: PLOS ONE allows preprint posting at any stage. No restrictions. If you posted to bioRxiv or medRxiv before submission, that's fine.

PLOS ONE reviews manuscripts for technical soundness only. Reviewers aren't asked to evaluate novelty or significance, just whether the study is methodologically sound and the conclusions are supported by the evidence.

This editorial philosophy means:

• Faster decisions: Median time from submission to first decision is around 30 days.
• Higher acceptance rate: Approximately 50-60% of submitted manuscripts are eventually published.
• Less subjectivity: Rejection is based on methodological flaws, not an editor's opinion about whether the finding is "interesting enough."

For researchers who have been through multiple rounds of rejection at selective journals, PLOS ONE offers a reliable path to publication for sound work that doesn't need a prestige stamp.

PLOS ONE makes sense in several specific scenarios:

1. Budget is tight: At $1,695, it's the cheapest reputable option. If your grant is running low or you don't have dedicated publication funds, PLOS ONE keeps costs manageable.
2. Speed matters: The faster review timeline and high acceptance rate mean your work gets published sooner.
3. Funder compliance is non-negotiable: Universal compliance with every major mandate. Zero risk of a compliance problem.
4. Your institution has an All-In deal: If so, it costs you literally nothing.
5. Technical soundness, not impact factor, is what you need: For datasets, methods papers, replication studies, or negative results that deserve the scientific record.

PLOS ONE isn't the right choice if journal prestige is the primary criterion for your career stage. For tenure cases at research-intensive universities or competitive grant applications, higher-IF journals like PNAS or Nature Communications carry more weight. But for the vast majority of scientific publications, PLOS ONE provides a solid, well-indexed, universally compliant home at a price that doesn't drain your research budget.

Before submitting anywhere, it's worth making sure your methodology and presentation are clean. Even at PLOS ONE, technical flaws in your manuscript lead to rejection. Run a free readiness scan to catch issues before reviewers do.